Li Haopeng, Zhou Juan, Wang Qinghua, Zhu Yaru, Zi Tong, Qin Xin, Zhao Yan, Jiang Wei, Li Xilei, Wang Xin'an, Xu Chengdang, Chen Xi, Wu Gang
Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200092, People's Republic of China.
Department of ICU, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200092, People's Republic of China.
J Inflamm Res. 2024 Nov 25;17:9583-9599. doi: 10.2147/JIR.S492858. eCollection 2024.
This study aims to evaluate the predictive value of the renal resistive index (RRI) and β2-microglobulin (β2-MG) for acute kidney injury (AKI) in urosepsis patients and to develop a clinical prediction model for AKI risk.
Data from 108 urosepsis patients at Tongji Hospital were analyzed. Patients were divided into AKI (67 patients) and non-AKI (41 patients) groups based on KDIGO guidelines. Univariate analysis identified potential AKI risk factors, which were further assessed using multivariate logistic regression. A nomogram was constructed based on significant predictors, with internal validation via the bootstrap method. The model's accuracy and clinical utility were evaluated using ROC curves and Decision Curve Analysis (DCA).
Multivariate analysis identified RRI, β2-MG, procalcitonin (PCT), and serum creatinine (Scr) as independent AKI risk factors. The combined predictive indicators yielded an AUC of 0.879, outperforming individual markers (P < 0.05). The prediction model achieved an AUC of 0.949, with high sensitivity (92.5%) and specificity (82.9%). Further analysis revealed that RRI, β2-MG, PCT, and APACHE II scores were independent predictors of poor prognosis in urosepsis-related AKI, with combined RRI and β2-MG predictions showing superior performance.
Elevated RRI, β2-MG, PCT, and Scr levels are independent predictors of AKI in urosepsis. RRI, β2-MG, PCT, and APACHE II scores also predict poor prognosis in urosepsis-related AKI. The nomogram combining these factors demonstrates high predictive accuracy and clinical applicability.
本研究旨在评估肾阻力指数(RRI)和β2微球蛋白(β2-MG)对尿脓毒症患者急性肾损伤(AKI)的预测价值,并建立AKI风险的临床预测模型。
分析了同济医院108例尿脓毒症患者的数据。根据KDIGO指南,将患者分为AKI组(67例)和非AKI组(41例)。单因素分析确定潜在的AKI危险因素,再通过多因素逻辑回归进一步评估。基于显著预测因素构建列线图,并通过自助法进行内部验证。使用ROC曲线和决策曲线分析(DCA)评估模型的准确性和临床实用性。
多因素分析确定RRI、β2-MG、降钙素原(PCT)和血清肌酐(Scr)为独立的AKI危险因素。联合预测指标的曲线下面积(AUC)为0.879,优于单个指标(P<0.05)。预测模型的AUC为0.949,具有高敏感性(92.5%)和特异性(82.9%)。进一步分析显示,RRI、β2-MG、PCT和急性生理与慢性健康状况评分系统II(APACHE II)评分是尿脓毒症相关AKI预后不良的独立预测因素,联合RRI和β2-MG预测表现更优。
RRI、β2-MG、PCT和Scr水平升高是尿脓毒症患者AKI的独立预测因素。RRI、β2-MG、PCT和APACHE II评分也可预测尿脓毒症相关AKI的不良预后。结合这些因素的列线图显示出高预测准确性和临床适用性。